image of Brianne Gebhardt
  • Telehealth Visits
bch logo

Brianne Gebhardt, NP, BSN

She | Her | HersPediatrics
Pediatric Bone Marrow Transplant (BMT), Cellular & Gene Therapy Mission Bay
877-822-4453
image of Brianne Gebhardt
image of Brianne Gebhardt
bch logo

Brianne Gebhardt, NP, BSN

She | Her | HersPediatrics
Pediatric Bone Marrow Transplant (BMT), Cellular & Gene Therapy Mission Bay
877-822-4453
  • Telehealth Visits

On this page

About me

Brianne Gebhardt is a nurse practitioner who cares for children needing blood or bone marrow transplants to treat cancers, blood disorders, metabolic disorders or other conditions. She has expertise in managing complications of transplantation and cancer treatments; these include various infections, hepatic veno-occlusive disease (in which some of the liver's veins are blocked), transplant-associated thrombotic microangiopathy (the formation of microscopic clots in small blood vessels, affecting red blood cells, platelets and organs) and graft-versus-host disease (in which stem cells transplanted from a donor attack the recipient's tissues).

Gebhardt earned a doctor of nursing practice degree at the University of Washington School of Nursing, followed by a one-year nurse practitioner fellowship in hematology and oncology and blood and marrow transplantation at Stanford Medicine.

Education

Board Certification

  • Family Nurse Practitioner, American Nurses Credentialing Center

School

  • DNP, University of Washington School of Nursing

Care Keywords

  • Services
    • Pediatrics

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.